COR
Price
$241.43
Change
-$2.03 (-0.83%)
Updated
Feb 21 closing price
Capitalization
48.42B
67 days until earnings call
PDCO
Price
$31.07
Change
+$0.01 (+0.03%)
Updated
Feb 21 closing price
Capitalization
2.48B
5 days until earnings call
Ad is loading...

COR vs PDCO

Header iconCOR vs PDCO Comparison
Open Charts COR vs PDCOBanner chart's image
Cencora
Price$241.43
Change-$2.03 (-0.83%)
Volume$1.06M
Capitalization48.42B
Patterson Companies
Price$31.07
Change+$0.01 (+0.03%)
Volume$707.17K
Capitalization2.48B
COR vs PDCO Comparison Chart
Loading...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COR vs. PDCO commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Hold and PDCO is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (COR: $243.46 vs. PDCO: $31.06)
Brand notoriety: COR and PDCO are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 85% vs. PDCO: 52%
Market capitalization -- COR: $48.42B vs. PDCO: $2.48B
COR [@Medical Distributors] is valued at $48.42B. PDCO’s [@Medical Distributors] market capitalization is $2.48B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 3 FA rating(s) are green whilePDCO’s FA Score has 2 green FA rating(s).

  • COR’s FA Score: 3 green, 2 red.
  • PDCO’s FA Score: 2 green, 3 red.
According to our system of comparison, PDCO is a better buy in the long-term than COR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 5 TA indicator(s) are bullish while PDCO’s TA Score has 2 bullish TA indicator(s).

  • COR’s TA Score: 5 bullish, 5 bearish.
  • PDCO’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, COR is a better buy in the short-term than PDCO.

Price Growth

COR (@Medical Distributors) experienced а -0.21% price change this week, while PDCO (@Medical Distributors) price change was +0.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.30%. For the same industry, the average monthly price growth was -0.61%, and the average quarterly price growth was +1.88%.

Reported Earning Dates

COR is expected to report earnings on Apr 30, 2025.

PDCO is expected to report earnings on Jun 25, 2025.

Industries' Descriptions

@Medical Distributors (-0.30% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($48.4B) has a higher market cap than PDCO($2.48B). COR has higher P/E ratio than PDCO: COR (26.47) vs PDCO (13.32). COR YTD gains are higher at: 8.603 vs. PDCO (0.648). COR has higher annual earnings (EBITDA): 3.71B vs. PDCO (384M). COR has more cash in the bank: 2.87B vs. PDCO (124M). PDCO has less debt than COR: PDCO (895M) vs COR (4.78B). COR has higher revenues than PDCO: COR (272B) vs PDCO (6.57B).
CORPDCOCOR / PDCO
Capitalization48.4B2.48B1,954%
EBITDA3.71B384M966%
Gain YTD8.6030.6481,327%
P/E Ratio26.4713.32199%
Revenue272B6.57B4,142%
Total Cash2.87B124M2,316%
Total Debt4.78B895M534%
FUNDAMENTALS RATINGS
COR vs PDCO: Fundamental Ratings
COR
PDCO
OUTLOOK RATING
1..100
8212
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
237
SMR RATING
1..100
1055
PRICE GROWTH RATING
1..100
3840
P/E GROWTH RATING
1..100
2222
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDCO's Valuation (22) in the Medical Distributors industry is significantly better than the same rating for COR (96) in the Real Estate Investment Trusts industry. This means that PDCO’s stock grew significantly faster than COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is somewhat better than the same rating for PDCO (37) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than PDCO’s over the last 12 months.

COR's SMR Rating (10) in the Real Estate Investment Trusts industry is somewhat better than the same rating for PDCO (55) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than PDCO’s over the last 12 months.

COR's Price Growth Rating (38) in the Real Estate Investment Trusts industry is in the same range as PDCO (40) in the Medical Distributors industry. This means that COR’s stock grew similarly to PDCO’s over the last 12 months.

COR's P/E Growth Rating (22) in the Real Estate Investment Trusts industry is in the same range as PDCO (22) in the Medical Distributors industry. This means that COR’s stock grew similarly to PDCO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORPDCO
RSI
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 25 days ago
60%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
44%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
63%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Ad is loading...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICSX15.60N/A
N/A
Lord Abbett International Equity R4
MEIKX50.98N/A
N/A
MFS Value R6
WAYFX17.80N/A
N/A
Waycross Focused Core Equity Fund
BGETX14.19-0.01
-0.04%
Baillie Gifford International Growth 2
NEFOX31.10-0.10
-0.32%
Natixis Oakmark A

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
-0.80%
MCK - COR
58%
Loosely correlated
+0.13%
CAH - COR
58%
Loosely correlated
+0.50%
OMI - COR
20%
Poorly correlated
-6.43%
SHTDF - COR
17%
Poorly correlated
N/A
HSIC - COR
15%
Poorly correlated
+0.28%
More

PDCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDCO has been loosely correlated with HSIC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PDCO jumps, then HSIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDCO
1D Price
Change %
PDCO100%
+0.06%
HSIC - PDCO
45%
Loosely correlated
+0.28%
ZYXI - PDCO
15%
Poorly correlated
-1.46%
OMI - PDCO
14%
Poorly correlated
-6.43%
CAH - PDCO
14%
Poorly correlated
+0.50%
COR - PDCO
12%
Poorly correlated
-0.80%
More